Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy.
Saved in:
| Title: | Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy. |
|---|---|
| Authors: | Saif, Faraz1 (AUTHOR) faraz.gintoki@gmail.com, Qureshi, Fakhra Nain2 (AUTHOR) fakhranain@gmail.com, Ahmad, Azaz3 (AUTHOR) drazazahmad181@gmail.com, Durrani, Fakeeda4 (AUTHOR) fakeedadurrani_92@yahoo.com, Azam, Noor Ul Ain5 (AUTHOR) noori89@gmail.com, Ullah, Imad1 (AUTHOR) imadkhan889990@gmail.com, Ahmed, Zia Ud Din1 (AUTHOR) ziauddin67@yahoo.com, Khan, Asif Riaz3 (AUTHOR) dr.asifriaz@gmail.com |
| Source: | Supportive Care in Cancer. Jun2026, Vol. 34 Issue 6, p1-9. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09414355 |
|---|---|
| DOI: | 10.1007/s00520-026-10847-z |
